Previous Page  98 / 391 Next Page
Information
Show Menu
Previous Page 98 / 391 Next Page
Page Background

NEWS LETTER 2 0 1 0

84

Divestiture

:

TheCBgavenumerous decisions on thebasis of divestiture

remedies. Indeed, in its

Roche

decision in 2003, the CB authorized an

operation of a concentration on the condition that one of the parties

divests its feed enzyme business. This decision does not include any

limitation as to area

2

. Following this decision, in the

Syngenta

decision

of 2004, the CB authorized the operation of a concentration on the

condition that one of the parties divests its sunflower seed business in

a designated area

3

. Recently, in its

Vatan Gazetesi

(Vatan Newspaper)

decision rendered in 2008, the CB authorized the operation of a

concentration because of two-year divesture commitments

4

.

Transfer of License

:

The CB gave three decisions related to this

subject. In the

Glaxo Wellcome

decision of 2000, the CB authorized

the merger of two drug companies on the condition that certain

drug brands in Turkey are transferred to third parties

5

. Following

this decision, the CB authorized, in its

Nazar trademarks

decision

of 2007, the operation of a concentration of two chewing gum

companies because of commitments to complete two successive

transfers of a brand

6

. Finally the CB authorized in 2008 the

operation of a concentration of two margarine companies based on

commitments to transfer certain commercial brands

7

.

Behavioral remedies set forth in CB’s decisions are as follows:

Limitation of the entrance and exit of designated brands during

certain periods:

The CB, in its

P&G

decision, authorized the

operation of a concentration of two toothpaste companies with such

remedies to be applied within the European Economic Area

8

.

Suspension of flights:

The CB in its

Lufthansa

decision granted

individual exemption to the operation of a concentration of two

airlines on the condition that they suspend some of their flights

9

.

2 Decision DSM N.V – Roche Holding AG, 11.09.2003, 03-60/730-342.

3 Decision Syngenta Crop Protecton AG – Astazenece Holdings B.V – Koninklijke Venderhave

Groep B.V., 29.07.2004, 04-49/673-171.

4 Decision Doğan Gazetecilik / Vatan Gazetesi,10.03.2008, 08-23/237-75.

5 Decision Glaxo Wellcome / SmithKline, 03.08.2000, 00-29/308-175.

6 Decision

Greencastle DRinks Limited – Jak AMRAM – Leon AMRAM – Filip AMRAM – Lolita

AMRAM,

23.08.

2007, 07-67/836-314

.

7 Decision Marmara Gıda / GıdaSa, 07.02.2008, 08-12/130-46.

8 Decision P&G, 08.09.2005, 05-55/836-228.

9 Decision Deutsche Lufthansa AG – Condor Flugdienst GmbH, 11.04.

2007, 07-31/323-119

.